LRRK2 and Parkinson disease: Finally, to assess whether alterations in LRRK2 and GCase activity levels in PD PBMCs were accompanied by alterations in cytokine release, we performed multiplexed immunoassays on conditioned media from plated PBMCs stimulated with IFN-γ and co-treated with MLi-2 for 18 h.